Loading...
  • Treatment
  • Treatment depends upon which type of myeloproliferative disorder is present, as well as the age and other health problems that the patient might have. (rightdiagnosis.com)
  • Although these agents have not been successful in curing CML, TKIs have been shown to achieve long-term disease control in a majority of treated patients and have become the initial treatment of choice. (oncolink.org)
  • Since the leukemic process involving the kidney may respond favorably to treatment, a renal biopsy should be considered in any patient presenting with unexplained severe or evolving kidney disease. (dovepress.com)
  • Prognosis and treatment for children diagnosed with MDS is dependent on the specific type of MDS, the severity of the disease, whether the MDS is a primary or secondary and if there is an available stem cell donor. (leukaemia.org.au)
  • Children with secondary MDS resulting from congenital diseases of the marrow may also be offered an allogeneic transplant as a treatment option. (leukaemia.org.au)
  • Treatment with other medications may also result in a temporary improvement of the disease. (leukaemia.org.au)
  • Occasionally, some children may have a more indolent disease and with supportive care such as blood transfusions, they may survive for many years without any active treatment. (leukaemia.org.au)
  • Dosing: Adult Note: Treatment may be continued until disease progression or unacceptable toxicity. (scribd.com)
  • type
  • The symptoms depend on the type of MPN the patient has. (aamds.org)
  • The purpose of the study is to compare sitagliptin and glipizide in lowering blood sugar in participants with type-2 diabetes mellitus (T2DM) and end-stage renal disease on dialysis who do not have adequate glycemic control. (clinicaltrials.gov)
  • blood
  • Doctors usually discover MPNs when doing routine blood work or when evaluating patients with some of the symptoms above. (aamds.org)
  • Some children with refractory cytopenia need only to be monitored with blood tests and may occasionally need blood transfusions to relieve symptoms, but their disease can remain stable for months or years. (leukaemia.org.au)
  • Most carriers of this McLeod blood group phenotype have acanthocytosis and elevated serum creatine kinase levels and are prone to develop a severe neurologic disorder resembling Huntington disease ( OMIM ). (mendelian.co)
  • relieve
  • Radiation therapy with high-energy rays or particles is sometimes used to relieve certain symptoms of MPN. (aamds.org)
  • burden
  • The symptomatic burden felt by MPN patients may be a result of the chronic inflammation associated with MPN, as several cytokines have been linked with different symptoms. (springer.com)